Biogenea Pharmaceuticals Ltd.

This early-phase trial is testing a personalized vaccine designed to treat glioma, a type of brain cancer. The vaccine is custom-made for each patient using their unique tumor profile, artificial intelligence (AI), and quantum mechanics models. The goal is to train the patient's …

This early study is testing a new, personalized vaccine designed by a special AI system. It is given along with standard chemotherapy and an immunotherapy drug to patients who have had surgery for stage III colon cancer. The main goal is to see if this three-part combination is s…